Pfizer receives FDA fast track designation for tafamidis for transthyretin cardiomyopathy
admin 7th June 2017 Uncategorised 0Pfizer
More: Pfizer receives FDA fast track designation for tafamidis for transthyretin cardiomyopathy
Source: MDlinx
© 1994 - 2024 B.M. Pharmaceuticals